Home Biocrates Life Sciences

Biocrates Life Sciences

acquired
-
Metabolomics Platform Developer

Basic Information

Biocrates Life Sciences AG Develops Metabolomics Platforms to Support Biomedical Research and the Discovery and Validation of Biomarkers for Complex Diseases. The company's platform includes an automated sample preparation workflow, integrating sensitive mass spectrometry methods and software that manages sample handling, data collection, and analysis to identify hundreds of metabolites, enabling physicians to quickly and reliably obtain comprehensive metabolic information.
Biocrates Life Sciences AG
Innsbruck,Tyrol,Austria
15~50 people
January 01, 2002
--